Business Description
Evome Medical Technologies Inc
NAICS : 423450
SIC : 3912
ISIN : CA45781J2074
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.08 | |||||
Equity-to-Asset | -0.1 | |||||
Debt-to-Equity | -5.09 | |||||
Debt-to-EBITDA | -1.12 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -3.87 | |||||
Beneish M-Score | -5.05 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 340 | |||||
3-Year EBITDA Growth Rate | -45.5 | |||||
3-Year EPS without NRI Growth Rate | -43.8 | |||||
3-Year FCF Growth Rate | -35.7 | |||||
3-Year Book Growth Rate | -43.8 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 22.34 | |||||
9-Day RSI | 33.78 | |||||
14-Day RSI | 38.85 | |||||
6-1 Month Momentum % | -31.25 | |||||
12-1 Month Momentum % | -56.86 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.51 | |||||
Quick Ratio | 0.24 | |||||
Cash Ratio | 0.04 | |||||
Days Inventory | 119.89 | |||||
Days Sales Outstanding | 50.73 | |||||
Days Payable | 70.59 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -33.2 | |||||
Shareholder Yield % | 2.08 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 33.8 | |||||
Operating Margin % | -11.37 | |||||
Net Margin % | -48.68 | |||||
FCF Margin % | 11.11 | |||||
ROE % | -676.99 | |||||
ROA % | -50.76 | |||||
ROIC % | -10.24 | |||||
ROC (Joel Greenblatt) % | -174.2 | |||||
ROCE % | -218.28 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.2 | |||||
Price-to-Free-Cash-Flow | 1.86 | |||||
Price-to-Operating-Cash-Flow | 1.8 | |||||
EV-to-EBIT | -1.23 | |||||
EV-to-EBITDA | -1.61 | |||||
EV-to-Revenue | 0.52 | |||||
EV-to-Forward-Revenue | 0.39 | |||||
EV-to-FCF | 4.68 | |||||
Earnings Yield (Greenblatt) % | -81.3 | |||||
FCF Yield % | 59.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Evome Medical Technologies Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 48.343 | ||
EPS (TTM) (C$) | -0.303 | ||
Beta | 1.44 | ||
Volatility % | 83.79 | ||
14-Day RSI | 38.85 | ||
14-Day ATR (C$) | 0.007569 | ||
20-Day SMA (C$) | 0.12525 | ||
12-1 Month Momentum % | -56.86 | ||
52-Week Range (C$) | 0.08 - 0.3 | ||
Shares Outstanding (Mil) | 82.7 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Evome Medical Technologies Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Evome Medical Technologies Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Evome Medical Technologies Inc Frequently Asked Questions
What is Evome Medical Technologies Inc(TSXV:EVMT)'s stock price today?
When is next earnings date of Evome Medical Technologies Inc(TSXV:EVMT)?
Does Evome Medical Technologies Inc(TSXV:EVMT) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |